Drugs / PF-04776548
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01045317 | Jan → Feb 2010 | HIV infectious disease | Pfizer | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-04776548 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01045317 ↗ |
| Known as | PF-4776548 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3219143 ↗ |
| Modality | Small molecule | — CHEMBL3219143 ↗ |
| Route | Intravenous | “via both intravenous and oral routes” NCT01045317 ↗ |
| Route | Oral | “via both intravenous and oral routes” NCT01045317 ↗ |